Reinhard Gluck

Title: Reinhard Gluck: Innovator in Immunostimulation

Introduction

Reinhard Gluck is a notable inventor based in Spiegel, Bern, Switzerland. He has made significant contributions to the field of immunology, particularly through his innovative work on reconstituted influenza virosomes. With a total of 2 patents, Gluck's inventions are paving the way for advancements in vaccine development.

Latest Patents

Gluck's latest patents include groundbreaking technologies in immunostimulation. One of his patents focuses on immunostimulating reconstituted influenza virosomes (IRIVs) that incorporate antigens into a functional virus envelope. This technology utilizes influenza hemagglutinin protein (HA) to induce fusion with cellular membranes, leading to the lysis of the IRIV after endocytosis by antigen-presenting cells. Another patent involves the use of hepatitis A virus in a reconstituted influenza virosome, which also includes HA or a peptide segment of HA.sub.2. This innovation aims to create a vaccine containing hepatitis A IRIVs, enhancing the efficacy of immunization.

Career Highlights

Reinhard Gluck is associated with the Schweiz Serum & Impfinstitut Bern, where he continues to develop his innovative ideas. His work has been instrumental in advancing the understanding and application of virosome technology in vaccines.

Collaborations

Gluck has collaborated with notable colleagues, including Robert Mischler and Ulrich Gluck. These partnerships have contributed to the successful development of his patented technologies.

Conclusion

Reinhard Gluck's contributions to immunology through his patents on reconstituted influenza virosomes represent a significant advancement in vaccine technology. His work continues to influence the field and offers promising avenues for future research and development.